Related Experiment Video

Updated: Mar 21, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.8K

Improving patient outcomes to targeted therapies in melanoma

Zeynep Eroglu1, Keiran S M Smalley1,2, Vernon K Sondak1

  • 1a The Department of Cutaneous Oncology , The Moffitt Cancer Center & Research Institute , Tampa , FL , USA.

Expert Review of Anticancer Therapy
|May 4, 2016
PubMed
Abstract

Insights

Targeted therapies, including BRAF and MEK inhibitors, have significantly improved outcomes for advanced melanoma patients. Combination therapies show superior results compared to chemotherapy and monotherapy.

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • Advanced melanoma with BRAFV600 mutation has seen improved outcomes with targeted therapies.
  • Targeted therapies offer superior progression-free and overall survival compared to chemotherapy.

Purpose of the Study:

  • To provide an overview of clinical outcomes for melanoma patients treated with targeted therapies.
  • To highlight the efficacy of BRAF and MEK inhibitors in advanced melanoma.

Main Methods:

  • Review of clinical trial data for BRAF and MEK inhibitors in melanoma.
  • Comparison of targeted therapy combinations versus monotherapy and chemotherapy.

Main Results:

  • BRAF and MEK inhibitors demonstrate higher tumor response rates than chemotherapy.
  • Combination therapy with BRAF and MEK inhibitors is superior to monotherapy.

Conclusions:

  • Targeted therapies represent a significant advancement in advanced melanoma treatment.
  • Ongoing research explores expanded use in earlier stages and other melanoma subtypes.
Keywords:
BRAFMEKMelanomaNRAScombination therapytargeted therapy

More Related Videos

A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K